The Gabelli Growth Innovators ETF Q1 2026 Commentary

The Gabelli Growth Innovators ETF (GGRW) returned (7.6)% in the first quarter, underperforming the S&P 500's (4.4)% decline by 3.2 percentage points. The fund added new positions in American Express, Booking Holdings, Caterpillar, Charles Schwab, Parker-Hannifin, and Sherwin-Williams, while top performance contributors were GE Vernova, Applied Materials, ASML Holding, Eaton, and Caterpillar. The update is mainly a portfolio positioning and attribution recap rather than a major market catalyst.

Analysis

The portfolio shift reads less like a generic growth basket and more like a targeted bet on “capital goods + networked financials” exposure to a still-resilient U.S. capex cycle. The highest-conviction names in the winners list cluster around electrification, semis, and industrial automation, which suggests the market is still paying for earnings durability and backlog visibility rather than pure multiple expansion. That matters because it favors suppliers with pricing power and after-market revenue, while leaving more cyclical end-demand players vulnerable if orders merely normalize rather than accelerate.

Second-order, the new buys imply a broadening of the “AI/industrial infrastructure” trade beyond the obvious mega-cap semis. If that leadership persists, the next beneficiaries are likely the picks-and-shovels around power management, thermal systems, and factory automation rather than the end customers; if it fades, these same names can de-rate quickly because positioning is crowded and expectations are now anchored to flawless execution. The weakest link in that chain is actually the industrial PMIs: any 1-2 month rollover in global manufacturing would hit the recent outperformers first, even if secular narratives stay intact.

The financial addition is more interesting as a sentiment tell than a near-term earnings catalyst. A capital-markets-sensitive franchise can outperform in a benign rate-cut / soft-landing setup, but it also gives the portfolio a clean read on consumer credit and wealth effects; if delinquency data or risk appetite soften over the next 1-3 quarters, that sleeve becomes a defensive tell rather than a growth lever. The broad takeaway is that the manager is leaning into names with visible cash conversion and recurring revenue, which is usually bullish until the market shifts from quality scarcity back to rate sensitivity.

Contrarian view: the move may be slightly late-cycle crowded, especially in industrials and automation where the market has already begun to pay for 2026 earnings. The better risk/reward may be in expressing the same thesis via a relative-value pair against lower-quality cyclicals or via call spreads, rather than outright longs, because upside from here likely depends on revisions continuing to surprise higher rather than multiple expansion. If consensus is right on a soft landing, these names work; if consensus is even modestly wrong, the drawdown can be sharp and fast.

Key Decisions for Investors

• Favor a 3-6 month long ETN / short XLI-style cyclicals pair: ETN is better insulated by electrification and backlog quality, while generic industrial exposure is more vulnerable to PMI disappointment. Use on weakness after any 1-2 week tape pullback; target mid-single-digit relative outperformance with limited macro beta.
• Initiate a tactical long GEV and AMAT basket on 1-2 day post-earnings or post-guidance selloffs, but express it with call spreads rather than common equity. Risk/reward is best if the market is pricing in near-perfect execution; upside is another 8-12% over 1-2 quarters, downside should be capped at premium paid.
• Pair long AXP vs short a more rate-sensitive, higher-credit-beta consumer financial basket over the next 1-2 quarters. The trade works if consumer balance sheets stay intact; cut if delinquency/charge-off data inflects higher for two consecutive prints.
• Avoid chasing PH and SHW at current levels outright; instead, set buy limits 5-7% below spot for a 6-12 month horizon. These names are good businesses, but the market often overpays for perceived quality right before demand normalizes.
• For BKNG, prefer selling put spreads into travel demand strength rather than outright long equity. The business is resilient, but the market is already rewarding leisure normalization; risk/reward improves only if consumer travel data re-accelerates for another quarter.